CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

ProNai Therapeutics

The downtown Grand Rapids skyline. WWJ file photo.

Michigan Tech Startups Get Funding From GR’s Grand Angels

The Grand Rapids private investor group Grand Angels announced its latest funding commitments to a group of Michigan startups.

WWJ Newsradio 950–02/17/2014

ProNAi

ProNAi Raises $12M Series C Financing To Expand Cancer Studies

The cancer drug developer ProNAi Therapeutics Inc. Monday announced the closing of a Series C preferred financing round of more than $12 million with existing and new investors.

WWJ Newsradio 950–01/13/2014

ProNAi

ProNai Therapeutics Reports Anti-Tumor Activity From Drug Canddiate

ProNai Therapeutics Inc. reported promising new results Sunday from an ongoing Phase II study of its lead drug candidate at the 55th Annual Meeting of the American Society for Hematology in New Orleans, La.

WWJ Newsradio 950–12/09/2013

ProNAi

ProNAi To Present Phase II Clinical Data For New Cancer Drug

ProNAi Therapeutics Inc., a developer of drugs that target cancer by interfering with cancer cells’ DNA, announced that data from its ongoing Phase II clinical study of its drug candidate PNT2258 will be presented at the 55th Annual Meeting of the American Society of Hematology in New Orleans Dec. 7-10.

WWJ Newsradio 950–11/10/2013

ProNAi

ProNAi Presents Cancer Drug Results, Expands Management Team

ProNAi Therapeutics Inc., a cancer drug development company, said last week that it had concluded its initial human clinical trial of PNT2258, a new type of nucleic acid drug.

WWJ Newsradio 950–11/11/2012

MVCA

MVCA Programs to Attract Investment, Entrepreneur Talent Gaining Traction

The Michigan Venture Capital Association’s programs to develop the state’s investment community are helping venture capitalists and their portfolio companies attract and retain top talent.

WWJ Newsradio 950–07/12/2012